"New Interleukin-15 Superagonist (IL-15 SA) Combined with Donor Lymphocyte Infusion (DLI) Significantly Enhances Graft-Versus-Tumor Activity after Allogeneic Hematopoietic Stem Cell Transplantation" by Cavan Bailey

Article

New Interleukin-15 Superagonist (IL-15 SA) Combined with Donor Lymphocyte Infusion (DLI) Significantly Enhances Graft-Versus-Tumor Activity after Allogeneic Hematopoietic Stem Cell Transplantation

Blood (2014)

Cavan Bailey, Thomas Jefferson University
Michelle M Panis, Thomas Jefferson University
Cihangir Buyukgoz, Thomas Jefferson University
Tulin Budak-Alpdogan, Thomas Jefferson University
Neal Flomenberg, Thomas Jefferson University
Onder Alpdogan, Thomas Jefferson University

Link

Disciplines

Medicine and Health Sciences and
Immunology and Infectious Disease

Publication Date

December 6, 2014

Citation Information

Cavan Bailey, Michelle M Panis, Cihangir Buyukgoz, Tulin Budak-Alpdogan, et al.. "New Interleukin-15 Superagonist (IL-15 SA) Combined with Donor Lymphocyte Infusion (DLI) Significantly Enhances Graft-Versus-Tumor Activity after Allogeneic Hematopoietic Stem Cell Transplantation" Blood Vol. 124 Iss. 21 (2014) p. 1118 - 1118
Available at: http://works.bepress.com/tulin-budak-alpdogan/3/